This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Multiple Energy Technologies Sues Hologenix for False and Misleading Claims Regarding Celliant

March 1, 2019

LOS ANGELES--(BUSINESS WIRE)--Feb 28, 2019--Multiple Energy Technologies LLC, the maker of Redwave®-brand bioceramics, filed a lawsuit today in the United States District Court of California, Central District, against Hologenix LLC for making false and misleading claims about the Hologenix competing product, Celliant®, in violation of the Lanham Act. MET believes that these false claims have persuaded customers, potential customers, manufacturers and consumers to switch from using Redwave or buying Redwave-containing products to using Celliant or buying Celliant-containing products, causing millions of dollars in damages to MET.

On its website and in social media and press releases, Hologenix has made false statements regarding its product, alternately stating that the Food and Drug Administration has “determined” that Celliant provides health benefits or that the FDA has “approved” Celliant. Hologenix has made these claims in its Twitter feed, on its Facebook page and in other social media. Hologenix has repeatedly used the hashtag “#FDAapproved” when tweeting about its product.

The false claims attracted supportive media attention in Huffington Post,ShapeInc., WWD Digital Daily, Gear Patrol and Talking Points Memo, which repeated Celliant’s “FDA approval.” As alleged in MET’s federal court complaint, in fact, the FDA has neither “approved” Celliant nor made any determination about its purported health benefits.

MET’s attorney, Barry W. Lee of Manatt, Phelps & Phillips, commented: “By claiming the FDA has approved Celliant when it has not, Hologenix is deceiving consumers and manufacturing partners by trading on the reputation of a federal agency. This is exactly the sort of unfair and deceptive practice that the Lanham Act and other federal laws are designed to prevent. And MET intends to vigorously pursue its rights and protect its product.”

About Manatt, Phelps & Phillips LLP

Manatt, Phelps & Phillips LLP is one of the nation’s leading law and consulting firms, with offices strategically located in California (Los Angeles, Orange County, Palo Alto, San Francisco and Sacramento), New York (New York City and Albany), Chicago and Washington, D.C. The firm represents a sophisticated client base — including Fortune 500, middle-market and emerging companies — across a range of practice areas and industry sectors. For more information, visit https://www.manatt.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190228006115/en/

CONTACT: Barry W. Lee, Esq.





SOURCE: Manatt, Phelps & Phillips LLP

Copyright Business Wire 2019.

PUB: 02/28/2019 09:22 PM/DISC: 02/28/2019 09:22 PM